Further information on the original study is available.
|Sponsor||University College London Hospitals NHS Foundation Trust|
|Funder||Motor Neurone Disease Association and NIHR|
|CI||Dr Richard Orrell|
|UK sites||London Queen square|
This was an open label extension study for patients who had completed the lithium carbonate trial.
The objective was to obtain further evidence of the safety of lithium carbonate in doses achieving levels of 0.4-0.8 mmol/l.